| Treatment of advanced bladder cancer by submucosal injection of methotrexate in the anorectal area. | |
| | |
MedLine Citation:
|
PMID: 1499627 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In 1988, Shafik et al. presented their first attempt to apply cytostatics in the treatment of pelvic malignancies. Experimentally and clinically, they studied the anal route for administration of methotrexate, and their first results showed that higher concentration of drugs can be achieved in the bladder wall compared to that in serum. Since December 1988, we have been engaged in experimental and clinical investigations of the possibilities this method might reveal. Experiments with animals have proven that submucosal injection of the cytostatic agent does not induce local changes. The clinical trial on 20 patients with tumors of stage T2-T4 has not shown side effects, either local or systemic. The treatment was well tolerated by the patients. Anorexia has been reported in 3, elevated temperature in 2 and leukopenia in 4 of 20 patients. Complete response has been documented in 3 (15%), partial response in 3 (15%), stabilization in 5 (25%) and progression of the disease in 9 (45%) of the patients. Mean duration of remissions was 10.3 months (range 9-12). The distribution of submucously injected contrast medium into the anorectal area has been studied by computerized tomography in 4 of the patients. Although our results do not support the original estimates of the inventors of the method, its ease of application, the possibility of out-patient administration and negligible side effects are sufficient arguments for performing further experimental and clinical studies. |
| | |
Authors:
|
C Damyanov; Z Tonchev; N Pavlova; A Ivanov |
Related Documents
:
|
637277 - Directional spinals in obstetric analgesia. 10534247 - Safety and efficacy of neurobloc (botulinum toxin type b) in type a-resistant cervical ... 19554227 - The effectiveness of sodium tetradecyl sulfate in the treatment of wrist ganglia. 2059227 - Treatment of de quervain's tenosynovitis with corticosteroids. a prospective study of t... 19381757 - Infective endocarditis in hemodialysis patients: clinical features, echocardiographic d... 6846697 - Mason gastric bypass. long-term follow-up and comparison with other gastric procedures. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: European urology Volume: 21 ISSN: 0302-2838 ISO Abbreviation: Eur. Urol. Publication Date: 1992 |
Date Detail:
|
Created Date: 1992-09-17 Completed Date: 1992-09-17 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7512719 Medline TA: Eur Urol Country: SWITZERLAND |
Other Details:
|
Languages: eng Pagination: 211-5 Citation Subset: IM |
Affiliation:
|
Clinic of Urology, Higher Medical Institute, Sofia, Bulgaria. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Rectal Animals Carcinoma, Transitional Cell / drug therapy*, epidemiology, radiography Female Follow-Up Studies Humans Male Methotrexate / administration & dosage*, therapeutic use Middle Aged Rats Rats, Inbred Strains Time Factors Tomography, X-Ray Computed Urinary Bladder Neoplasms / drug therapy*, epidemiology, radiography |
| Chemical | |
Reg. No./Substance:
|
59-05-2/Methotrexate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Topical chemoprophylaxis of superficial bladder cancer with mitomycin C and adjuvant hyaluronidase.
Next Document: Frequency of urogenital tuberculosis in an unselected autopsy series from 1928 to 1949 and 1976 to 1...